Cargando…
A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
Peptides have great potential as therapeutic agents, however, their clinic applications are severely hampered by their instability and short circulation half-life. Zero-order release carriers could not only extend the circulation lifetime of peptides, but also maintain the plasma drug level constant...
Autores principales: | Zhao, Ya-Nan, Xu, Xiaoyu, Wen, Na, Song, Rui, Meng, Qingbin, Guan, Ying, Cheng, Siqi, Cao, Danni, Dong, Yansheng, Qie, Jiankun, Liu, Keliang, Zhang, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514143/ https://www.ncbi.nlm.nih.gov/pubmed/28717204 http://dx.doi.org/10.1038/s41598-017-05898-6 |
Ejemplares similares
-
Novel anti-HIV peptides containing multiple copies of artificially designed heptad repeat motifs
por: Shi, Weiguo, et al.
Publicado: (2008) -
3D Printing of Tunable Zero-Order Release Printlets
por: Fina, Fabrizio, et al.
Publicado: (2020) -
Zero-Order Controlled Release of Water-Soluble Drugs
Using a Marker Pen Platform
por: Li, Xiaosi, et al.
Publicado: (2021) -
Zero-order switches and developmental thresholds
por: Goldbeter, Albert
Publicado: (2005) -
Preparation and Sustained-Release Performance of PLGA Microcapsule Carrier System
por: Ren, Shuaikai, et al.
Publicado: (2021)